These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28948331)

  • 1. The eye as a complement dysregulation hotspot.
    Clark SJ; Bishop PN
    Semin Immunopathol; 2018 Jan; 40(1):65-74. PubMed ID: 28948331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement System and Potential Therapeutics in Age-Related Macular Degeneration.
    Park YG; Park YS; Kim IB
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement regulation in the eye: implications for age-related macular degeneration.
    Wilke GA; Apte RS
    J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The link between morphology and complement in ocular disease.
    Mohlin C; Sandholm K; Ekdahl KN; Nilsson B
    Mol Immunol; 2017 Sep; 89():84-99. PubMed ID: 28622910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option.
    Qin S; Dong N; Yang M; Wang J; Feng X; Wang Y
    J Immunol Res; 2021; 2021():9945725. PubMed ID: 34368372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related macular degeneration and the complement system.
    Khandhadia S; Cipriani V; Yates JR; Lotery AJ
    Immunobiology; 2012 Feb; 217(2):127-46. PubMed ID: 21868123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of complement system in ocular diseases including uveitis and macular degeneration.
    Jha P; Bora PS; Bora NS
    Mol Immunol; 2007 Sep; 44(16):3901-8. PubMed ID: 17768108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement system and age-related macular degeneration: drugs and challenges.
    Wu J; Sun X
    Drug Des Devel Ther; 2019; 13():2413-2425. PubMed ID: 31409975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelation Between Oxidative Stress and Complement Activation in Models of Age-Related Macular Degeneration.
    Pujol-Lereis LM; Schäfer N; Kuhn LB; Rohrer B; Pauly D
    Adv Exp Med Biol; 2016; 854():87-93. PubMed ID: 26427398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for complement and inflammation in AMD: open questions.
    Karagianni N; Adamis AP
    Adv Exp Med Biol; 2010; 703():1-7. PubMed ID: 20711703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complement system in age-related macular degeneration.
    Armento A; Ueffing M; Clark SJ
    Cell Mol Life Sci; 2021 May; 78(10):4487-4505. PubMed ID: 33751148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the complement system for the management of retinal inflammatory and degenerative diseases.
    Xu H; Chen M
    Eur J Pharmacol; 2016 Sep; 787():94-104. PubMed ID: 26948311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue.
    Kawa MP; Machalinska A; Roginska D; Machalinski B
    J Immunol Res; 2014; 2014():483960. PubMed ID: 25276841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From compliment to insult: genetics of the complement system in physiology and disease in the human retina.
    Mullins RF; Warwick AN; Sohn EH; Lotery AJ
    Hum Mol Genet; 2017 Aug; 26(R1):R51-R57. PubMed ID: 28482029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related macular degeneration: A disease of extracellular complement amplification.
    de Jong S; Tang J; Clark SJ
    Immunol Rev; 2023 Jan; 313(1):279-297. PubMed ID: 36223117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation and inhibition: a delicate balance.
    Sjöberg AP; Trouw LA; Blom AM
    Trends Immunol; 2009 Feb; 30(2):83-90. PubMed ID: 19144569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement system and age-related macular degeneration.
    Sivaprasad S; Chong NV
    Eye (Lond); 2006 Aug; 20(8):867-72. PubMed ID: 16410816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Challenges and Promise of Complement Therapeutics for Ocular Diseases.
    Park DH; Connor KM; Lambris JD
    Front Immunol; 2019; 10():1007. PubMed ID: 31156618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation as a biomarker for Alzheimer's disease.
    Aiyaz M; Lupton MK; Proitsi P; Powell JF; Lovestone S
    Immunobiology; 2012 Feb; 217(2):204-15. PubMed ID: 21856034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.